[go: up one dir, main page]

HK1060971A1 - Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt - Google Patents

Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt Download PDF

Info

Publication number
HK1060971A1
HK1060971A1 HK04103826A HK04103826A HK1060971A1 HK 1060971 A1 HK1060971 A1 HK 1060971A1 HK 04103826 A HK04103826 A HK 04103826A HK 04103826 A HK04103826 A HK 04103826A HK 1060971 A1 HK1060971 A1 HK 1060971A1
Authority
HK
Hong Kong
Prior art keywords
dosage form
administered parenterally
parenterally according
ethylene oxide
regulators
Prior art date
Application number
HK04103826A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1060971B (en
Inventor
Johannes Bartholomäus
Heinrich Kugelmann
Original Assignee
Grunenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grunenthal Gmbh filed Critical Grunenthal Gmbh
Publication of HK1060971A1 publication Critical patent/HK1060971A1/xx
Publication of HK1060971B publication Critical patent/HK1060971B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK04103826.0A 2000-11-28 2001-11-27 Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt HK1060971B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE20001059020 2000-11-28
DE10059020A DE10059020A1 (de) 2000-11-28 2000-11-28 Parenteral applizierbare Darreichungsformen
PCT/EP2001/013789 WO2002043723A1 (de) 2000-11-28 2001-11-27 Parental applizierbare darreichungsformen enthaltend eine suspension des salzes aus tramadol und diclofenac

Publications (2)

Publication Number Publication Date
HK1060971A1 true HK1060971A1 (en) 2004-09-03
HK1060971B HK1060971B (en) 2006-12-22

Family

ID=

Also Published As

Publication number Publication date
DE10059020A1 (de) 2002-05-29
CN1477955A (zh) 2004-02-25
EP1368016A1 (de) 2003-12-10
CN100384410C (zh) 2008-04-30
US20030203037A1 (en) 2003-10-30
DE50109572D1 (de) 2006-05-24
EP1368016B1 (de) 2006-04-19
CY1105625T1 (el) 2010-12-22
PT1368016E (pt) 2006-08-31
JP4188084B2 (ja) 2008-11-26
AU2002224896A1 (en) 2002-06-11
ES2262703T3 (es) 2006-12-01
JP2004514692A (ja) 2004-05-20
DK1368016T3 (da) 2006-07-31
US6875447B2 (en) 2005-04-05
WO2002043723A1 (de) 2002-06-06
ATE323477T1 (de) 2006-05-15

Similar Documents

Publication Publication Date Title
KR100722502B1 (ko) 사이프로플록사신 및 덱사메타손 함유 국소용 현탁제
JP5887368B2 (ja) 共溶媒処方物
US6147122A (en) Propofol composition containing sulfite
TWI495469B (zh) 含有氟喹諾酮抗生素藥物之經改良藥學組成物
US12168011B2 (en) Formulation production process
KR20210141448A (ko) 안구 표면 질환을 치료하기 위한 안과용 약학 조성물 및 방법
KR20130050394A (ko) 수의학 약물에서 멜록시캄 제형의 용도
US6875447B2 (en) Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt
RU2286774C2 (ru) Препарат эсмолола
KR102100271B1 (ko) 조절된 방출 조성물 및 이들의 사용 방법
HK1060971B (en) Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt
EP1119373A1 (en) Oxybutynin formulations and methods of use
CN111565761A (zh) 荧光素和丁氧普鲁卡因组合物
US7838034B2 (en) Intravenous pharmaceutical form of administration
WO2010082092A1 (en) Propofol based anesthetic with preservative
KR20190138858A (ko) 목시플록사신이 담긴 사전 충전형 시린지
AU2015261543B2 (en) Controlled release compositions and their methods of use
EP2934524B1 (en) Penethamate veterinary injectable formulations
NZ607636A (en) Controlled release compositions and their methods of use
WO2000067753A1 (en) Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate)

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20131127